Cargando…

High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice

SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 defi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kaoru, Yamada, Kenichiro, Fukuhara, Yayoi, Tsuji, Ai, Shibata, Katsumi, Wakamatsu, Nobuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493381/
https://www.ncbi.nlm.nih.gov/pubmed/28665968
http://dx.doi.org/10.1371/journal.pone.0180279
_version_ 1783247495171670016
author Suzuki, Kaoru
Yamada, Kenichiro
Fukuhara, Yayoi
Tsuji, Ai
Shibata, Katsumi
Wakamatsu, Nobuaki
author_facet Suzuki, Kaoru
Yamada, Kenichiro
Fukuhara, Yayoi
Tsuji, Ai
Shibata, Katsumi
Wakamatsu, Nobuaki
author_sort Suzuki, Kaoru
collection PubMed
description SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 deficiency and whether administration of high-dose thiamine prevents neurodegeneration, we generated homozygous Slc19a3 E314Q knock-in (KI) mice harboring the mutation corresponding to the human SLC19A3 E320Q, which is associated with the severe form of THMD2. Homozygous KI mice and previously reported homozygous Slc19a3 knock-out (KO) mice fed a thiamine-restricted diet (thiamine: 0.60 mg/100 g food) died within 30 and 12 days, respectively, with dramatically decreased thiamine concentration in the blood and brain, acute neurodegeneration, and astrogliosis in the submedial nucleus of the thalamus and ventral anterior-lateral complex of the thalamus. These findings may bear some features of thiamine-deficient mice generated by pyrithiamine injection and a thiamine-deficient diet, suggesting that the primary cause of THMD2 could be thiamine pyrophosphate (TPP) deficiency. Next, we analyzed the therapeutic effects of high-dose thiamine treatment. When the diet was reverted to a conventional diet (thiamine: 1.71 mg/100 g food) after thiamine restriction, all homozygous KO mice died. In contrast, when the diet was changed to a high-thiamine diet (thiamine: 8.50 mg/100 g food) after thiamine restriction, more than half of homozygous KO mice survived, without progression of brain lesions. Unexpectedly, when the high-thiamine diet of recovered mice was reverted to a conventional diet, some homozygous KO mice died. These results showed that acute neurodegeneration caused by thiamine deficiency is preventable in most parts, and prompt high-dose thiamine administration is critical for the treatment of THMD2. However, reduction of thiamine should be performed carefully to prevent recurrence after recovery of the disease.
format Online
Article
Text
id pubmed-5493381
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54933812017-07-18 High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice Suzuki, Kaoru Yamada, Kenichiro Fukuhara, Yayoi Tsuji, Ai Shibata, Katsumi Wakamatsu, Nobuaki PLoS One Research Article SLC19A3 deficiency, also called thiamine metabolism dysfunction syndrome-2 (THMD2; OMIM 607483), is an autosomal recessive neurodegenerative disorder caused by mutations in SLC19A3, the gene encoding thiamine transporter 2. To investigate the molecular mechanisms of neurodegeneration in SLC19A3 deficiency and whether administration of high-dose thiamine prevents neurodegeneration, we generated homozygous Slc19a3 E314Q knock-in (KI) mice harboring the mutation corresponding to the human SLC19A3 E320Q, which is associated with the severe form of THMD2. Homozygous KI mice and previously reported homozygous Slc19a3 knock-out (KO) mice fed a thiamine-restricted diet (thiamine: 0.60 mg/100 g food) died within 30 and 12 days, respectively, with dramatically decreased thiamine concentration in the blood and brain, acute neurodegeneration, and astrogliosis in the submedial nucleus of the thalamus and ventral anterior-lateral complex of the thalamus. These findings may bear some features of thiamine-deficient mice generated by pyrithiamine injection and a thiamine-deficient diet, suggesting that the primary cause of THMD2 could be thiamine pyrophosphate (TPP) deficiency. Next, we analyzed the therapeutic effects of high-dose thiamine treatment. When the diet was reverted to a conventional diet (thiamine: 1.71 mg/100 g food) after thiamine restriction, all homozygous KO mice died. In contrast, when the diet was changed to a high-thiamine diet (thiamine: 8.50 mg/100 g food) after thiamine restriction, more than half of homozygous KO mice survived, without progression of brain lesions. Unexpectedly, when the high-thiamine diet of recovered mice was reverted to a conventional diet, some homozygous KO mice died. These results showed that acute neurodegeneration caused by thiamine deficiency is preventable in most parts, and prompt high-dose thiamine administration is critical for the treatment of THMD2. However, reduction of thiamine should be performed carefully to prevent recurrence after recovery of the disease. Public Library of Science 2017-06-30 /pmc/articles/PMC5493381/ /pubmed/28665968 http://dx.doi.org/10.1371/journal.pone.0180279 Text en © 2017 Suzuki et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Suzuki, Kaoru
Yamada, Kenichiro
Fukuhara, Yayoi
Tsuji, Ai
Shibata, Katsumi
Wakamatsu, Nobuaki
High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice
title High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice
title_full High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice
title_fullStr High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice
title_full_unstemmed High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice
title_short High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice
title_sort high-dose thiamine prevents brain lesions and prolongs survival of slc19a3-deficient mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493381/
https://www.ncbi.nlm.nih.gov/pubmed/28665968
http://dx.doi.org/10.1371/journal.pone.0180279
work_keys_str_mv AT suzukikaoru highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice
AT yamadakenichiro highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice
AT fukuharayayoi highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice
AT tsujiai highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice
AT shibatakatsumi highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice
AT wakamatsunobuaki highdosethiaminepreventsbrainlesionsandprolongssurvivalofslc19a3deficientmice